ExlService Holdings, Inc. — Q1 2024 Form 10-Q
Business context and reporting period
Unaudited results cover the three months ended March 31, 2024, compared with Q1 2023. ExlService provides data analytics and digital operations and solutions, including AI-enabled services, across Insurance, Healthcare, Emerging Business and Analytics. Most revenue came from the U.S. (83.0%) and U.K. (11.5%).
Key financial metrics
| Metric | Q1 2024 | Q1 2023 / prior date |
|---|---|---|
| Revenue | $436.5 million | $400.6 million; up 9.0% |
| Gross profit / margin | $163.1 million / 37.4% | $149.2 million / 37.2% |
| Operating income / margin | $61.5 million / 14.1% | $59.4 million / 14.8% |
| Net income / diluted EPS | $48.8 million / $0.29 | $51.3 million / $0.30 |
| Operating cash flow | $(21.9) million | $16.0 million |
| Cash, cash equivalents and short-term investments | $246.2 million | $203.8 million at March 31, 2023 |
| Total borrowings | $345.0 million | $200.0 million at December 31, 2023 |
Cash, cash equivalents and restricted cash ended the quarter at $117.2 million, down from $145.4 million at year-end 2023. Capital expenditures were $11.3 million; operating cash flow less capital expenditures was approximately $(33.1) million. The current portion of borrowings was $65.0 million; the remaining $280.0 million is due in 2027. The company reported compliance with credit-facility covenants.
Material changes versus the prior comparable period
- Revenue growth was led by Insurance (+15.2%), Emerging Business (+12.4%) and Analytics (+4.9%); Healthcare revenue declined 1.7%.
- Gross margin improved 20 basis points, while operating margin declined 70 basis points. Higher employee, technology, sales and marketing costs contributed to operating expense growth of 13.2%, faster than revenue growth.
- Net income fell 5.0%, primarily because income tax expense rose to $13.8 million from $8.1 million; the effective tax rate increased to 22.0% from 13.6%.
- Operating cash flow shifted to an outflow, reflecting working-capital needs, lower cash earnings and contingent-consideration payments, including $11.0 million related to the Clairvoyant acquisition.
- Debt rose by $145.0 million net during the quarter. The company entered a $125.0 million accelerated share repurchase agreement and received an initial 3.35 million shares. It also authorized a $500 million repurchase program, with $375 million remaining at quarter-end.
Outlook, commentary, risks and unusual items
- Management expects 2024 capital expenditures of $50–$55 million and says existing liquidity and sources are expected to meet cash requirements over the next 12 months. No full-year revenue or earnings guidance is stated in the provided filing text.
- In April 2024, the company initiated a restructuring expected to affect less than 2% of its global workforce, with completion expected by the end of Q2 2024. Severance charges are expected; the amount is not specified.
- Management cites risks including client concentration and contract termination, long sales cycles, wage inflation and hiring, competition and pricing pressure, AI-related execution, cybersecurity, foreign exchange, and international tax and regulatory matters. The top ten clients generated 33.3% of Q1 revenue; no single client exceeded 10%.
- Indian tax matters include transfer-pricing demands of $36.1 million, net of advance payments, and VAT demands of $5.5 million. The company has not accrued liabilities for these matters, believes its positions will be sustained, and has provided payments and/or guarantees as disclosed. Management says pending litigation losses cannot be reasonably estimated.
- Other notable items: the company reported no goodwill impairment indicators at March 31; Q1 included a $0.6 million favorable fair-value change in contingent consideration. Foreign-currency translation and other comprehensive loss reduced comprehensive income versus net income.
- Disclosure controls were assessed as effective, with no material change in internal control over financial reporting reported during the quarter.
Investor verification priorities
- Track whether revenue growth converts to operating income and cash generation, particularly as labor, cloud technology and AI investment costs evolve.
- Review receivables, unbilled receivables and days sales outstanding (66 days, versus 65 a year earlier), alongside future operating cash flow.
- Monitor debt, interest rates and liquidity after the quarter’s borrowing increase and share repurchases; verify final settlement of the ASR agreement, expected in July 2024 or potentially earlier.
- Assess segment trends, especially continued Healthcare softness and margin pressure in Analytics and Emerging Business.
- Follow the restructuring’s actual severance costs and completion, and developments in Indian tax disputes and other contingencies.